|Bid||5.00 x 1400|
|Ask||5.20 x 1100|
|Day's Range||5.07 - 5.35|
|52 Week Range||2.95 - 6.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 24, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.50|
The Zacks Analyst Blog Highlights: BG, Harvard Bioscience, Vertex Energy, Hallmark and Summer Infant
Penny stocks approaching key price levels dominate September's technical analysis buy list, telling interested traders to build watch lists and track progress while awaiting fruitful buying signals or reversals that break bullish patterns. First, establish the price level that is likely to attract strong buying interest. Second, look for the price level that is likely to attract strong selling interest.
Harvard Bioscience Inc. (hbio) said Chief Financial Officer Robert Gagnon has resigned, effective Aug. 31, after about five years in the role. The life sciences company said in a statement that the resignation "was not the result of any matters which, to the company's knowledge, would have an adverse impact on the integrity of the company's financial statement or the results of operation." The company said it has begun a search for a new CFO. Gagnon was appointed CFO on Nov. 1, 2013.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 26) ADMA Biologics Inc (NASDAQ: ADMA )(announced it has addressed ...
HOLLISTON, Mass., July 26, 2018-- Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three ...
Harvard Bioscience, Inc. (HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2018 after market trading hours on Thursday, July 26, 2018. Investors can access the live conference call by dialing the following phone numbers: toll-free 1-888-771-4371, or international: 1-847-585-4405, and referencing the conference ID# 47296710. The conference will be simultaneously webcast and can be accessed through the Harvard Bioscience website.
Harvard Bioscience Inc (NASDAQ:HBIO), a life sciences company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqGM.Read More...
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Wednesday reported a loss of $4.1 million in its first quarter. On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 11 cents. The medical instruments maker posted revenue of $26.8 million in the period.
For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...
There are other stocks too outside these household names with a good Zacks Rank that are also great growth stocks. Which Tech Stocks to Pick? To cash in on the favorable technology trends, this is the right time to add a few technology stocks that have growth potential.